ClinicalTrials.govpublic full text
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
tuberculosis, mycobacterium tuberculosis, antigen 85a, modified vaccinia virus ankara (mva)., interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 900618
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.